Ocugen Expands Ophthalmology Portfolio

PRESS RELEASE: Ocugen, Inc., a biopharmaceutical company developing treatments for sight-threatening diseases, today announced that it licensed a clinical-stage asset from the University of Illinois at Chicago (UIC) to be developed for the treatment...